IN2013MU02366A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02366A
IN2013MU02366A IN2366MU2013A IN2013MU02366A IN 2013MU02366 A IN2013MU02366 A IN 2013MU02366A IN 2366MU2013 A IN2366MU2013 A IN 2366MU2013A IN 2013MU02366 A IN2013MU02366 A IN 2013MU02366A
Authority
IN
India
Prior art keywords
relates
present
agomelatine
effective amount
time period
Prior art date
Application number
Inventor
Verma Sumitkumar
Chhunchha Alpesh
Dhavale Satyavan
Sehgal Ashish
Original Assignee
Astron Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astron Res Ltd filed Critical Astron Res Ltd
Priority to IN2366MU2013 priority Critical patent/IN2013MU02366A/en
Publication of IN2013MU02366A publication Critical patent/IN2013MU02366A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

This present invention relates to sustained release pharmaceutical composition of Agomelatine. The invention is particularly suitable for once-a-day solid oral pharmaceutical dosage forms which release therapeutically effective amount of the active ingredient over an extended time period. Further, the present invention relates to process for the preparation of the same.
IN2366MU2013 2013-07-15 2013-07-15 IN2013MU02366A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2366MU2013 IN2013MU02366A (en) 2013-07-15 2013-07-15

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2366MU2013 IN2013MU02366A (en) 2013-07-15 2013-07-15

Publications (1)

Publication Number Publication Date
IN2013MU02366A true IN2013MU02366A (en) 2015-06-19

Family

ID=54396599

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2366MU2013 IN2013MU02366A (en) 2013-07-15 2013-07-15

Country Status (1)

Country Link
IN (1) IN2013MU02366A (en)

Similar Documents

Publication Publication Date Title
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
MX2021000550A (en) Tofacitinib oral sustained release dosage forms.
EA201690962A1 (en) COMPOSITIONS
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12015501096A1 (en) Composition for immediate and extended release
MX2018000419A (en) Substituted amide derivatives having multimodal activity against pain.
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
MY179509A (en) Piperazine derivatives having multimodal activity against pain
MX2015011536A (en) Novel sulfonamide trpa1 receptor antagonists.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
UA117154C2 (en) S1p3 antagonists
MX366829B (en) Itraconazole compositions and dosage forms, and methods of using the same.
MX2017013099A (en) Methods for the treatment of inflammatory disorders.
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
MX2017013633A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles.
BR112016007031A8 (en) solid oral pharmaceutical composition, process for preparing the solid oral pharmaceutical composition, and use of a solid oral pharmaceutical composition
MX2018010065A (en) Oral dosage form comprising rifaximin in form beta.
PH12020500120A1 (en) Pharmaceutical compositions
IN2013MU02366A (en)
WO2014122671A3 (en) Solid oral compositions of saxagliptin
TN2015000524A1 (en) Pharmaceutical compositions
IN2013MU03428A (en)